In collaboration with Krka d.d., we developed a new key-step for the synthesis of the anticholesterolemic drug, ezetimib. Using our laboratory developed chiral ruthenium-based transfer hydrogenation catalyst, we obtained a key-intermediate in high enantiomeric excess and chemical purity.
F.32 International patent
COBISS.SI-ID: 4032026